Concern Over AstraZeneca Vaccine Data
over 4 years in St.Lucia Times
In an unusual statement released early Tuesday, the National Institute of Allergy and Infectious Diseases said the independent board that reviews data from multiple Covid-19 vaccine candidates has raised concerns about AstraZeneca’s announcement of efficacy data from its vaccine trial. “The DSMB expressed concern that AstraZeneca may have included outdated information from that trial, which […]
This article Concern Over AstraZeneca Vaccine Data appeared first on St. Lucia Times News.